Filing Flows › Health Care › Milestone Scientific (MLSS)
Milestone Scientific (MLSS) earnings and revenue breakdown
Latest: Q2 2026 · 10-Q filed Aug 13, 2026 · Milestone Scientific (MLSS) Q2 2026 earnings results →
Q2 2026 Revenue up 22% year over year to $2.8M · 37¢ of every $1 of revenue lost · operating margin -37.4%
Milestone Scientific made $2.8M in Q2 2026 (+22% Y/Y). Operating margin -37.4%, net loss $1.1M. See where every dollar goes — costs, profit and cash — as a Sankey from the 10-Q filed Aug 13, 2026.
Drawing the Sankey…
Open the interactive Sankey → click any line for what the company wrote about it, compare Y/Y and Q/Q, export as PNG or PDF
What changed this quarter
Revenue was $2.8M in Q2 2026, up 22% year over year and up 31% from the previous quarter.
Gross margin was 67.2%, down 2.4 points from Q2 2025. Operating costs exceeded revenue by $1.1M, an operating margin of -37.4%. Operating expenses fell 4% while revenue rose 22%. The quarter ended with a net loss of $1.1M, wider than the previous quarter's $840K loss.
Operating cash flow was −$585K. Non-cash charges added back $20K of depreciation and amortization and $310K of share-based compensation. Working capital and other items added $145K. Capital expenditures of $4K exceeded it, leaving free cash flow of −$589K.
Quarterly history
| Quarter | Form | Filed | Revenue | Y/Y | Op. margin | Net earnings | Op. cash flow |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 10-Q | Aug 13, 2026 | $2.8M | +22% | -37.4% | −$1.1M | −$585K |
| Q1 2026 | 10-Q | May 13, 2026 | $2.2M | -3% | -38.3% | −$840K | $87K |
| Q4 2025 | 10-K | Mar 31, 2026 | $2.1M | +2% | -52.5% | −$1.1M | −$226K |
| Q3 2025 | 10-Q | Nov 13, 2025 | $2.4M | -6% | -48.1% | −$1.2M | $82K |
| Q2 2025 | 10-Q | Aug 14, 2025 | $2.3M | +25% | -63.9% | −$1.5M | −$1.8M |
| Q1 2025 | 10-Q | May 15, 2025 | $2.2M | -0.7% | -89.5% | −$2.0M | −$1.0M |
| Q4 2024 | 10-K | Apr 15, 2025 | $2.0M | -11% | -101.4% | −$2.0M | −$1.5M |
Charts
Interactive views
The same charts as the app — open one to draw it.
💵Where each $1 goesinteractive
Loading the interactive chart…
🌏Named in Asian annual reportsinteractive
Loading the interactive chart…
🔄Rotation against the market and its industry (RRG)interactive
Loading the interactive chart…
🔍Earnings qualityinteractive
Loading the interactive chart…
⚖️Fair value by methodinteractive
Loading the interactive chart…
🔭Outlook & guidanceinteractive
Loading the interactive chart…
📈Investments: gains and what it boughtinteractive
Loading the interactive chart…
🏭Its industry’s money flow (input-output)interactive
Loading the interactive chart…
About Milestone Scientific
Milestone Scientific Inc. was incorporated in the State of Delaware in August 1989. The Company develops and commercializes proprietary computer-controlled drug delivery systems designed to enhance the safety, precision, and patient experience associated with subcutaneous injections and fluid aspiration procedures. The Company’s core technology platform, Dynamic Pressure Sensing® (“DPS”) Technology, controls flow rate and measures pressure at the needle tip in real time. DPS Technology is incorporated into both the Company’s dental and medical products and supports clinical applications, including local anesthesia delivery, epidural space identification in regional anesthesia procedures, and intra-articular joint injections.
In its own words, from its 10-K, filed Mar 31, 2026.
Milestone Scientific against its Orthopedic, Prosthetic & Surgical Appliances & Supplies peers
The largest companies of the same SEC industry, each at its latest quarter. Revenue growth: +22% against the peers' median +10%. Operating margin: -37.4% against the peers' median 16.4%.
| Company | Quarter | Revenue | Y/Y | Op. margin |
|---|---|---|---|---|
| MLSS Milestone Scientific | Q2 2026 | $2.8M | +22% | -37.4% |
| ISRG Intuitive Surgical | Q3 2026 | $3.0B | +22% | 19.4% |
| ZBH Zimmer Biomet Holdings | Q3 2026 | $2.1B | +3% | 14.9% |
| EW Edwards Lifesciences | Q3 2026 | $1.7B | +10% | 17.4% |
| STE Steris | Q2 FY27 | $1.6B | +9% | 18.5% |
| ALGN Align Technology | Q3 2026 | $1.0B | +2% | 16.7% |
| ENOV Enovis | Q3 2026 | $559M | +2% | 0.6% |
| MSA MSA Safety | Q3 2026 | $536M | +14% | 16.4% |
| CDRE Cadre Holdings | Q3 2026 | $203M | +30% | 14.0% |
Source: Milestone Scientific 10-Q on SEC EDGAR · CIK 855683 · Orthopedic, Prosthetic & Surgical Appliances & Supplies
13F: who owns MLSS and who is buying
More on MLSS
History
Every quarter: Q2 2026 results · Q1 2026 results · Q4 2025 results · Q3 2025 results · Q2 2025 results · Q1 2025 results · Q4 2024 results